Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: DNB stock price vs CXW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CXW's multiple
Needs CXW P/S.
Implied fair value · at DNB's multiple
Needs DNB P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
11 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Dun & Bradstreet Holdings, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
CORECIVIC, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
EQUIFAX INC
DNB vs EFX
FAIR ISAAC CORP
DNB vs FICO
TransUnion
DNB vs TRU
Root, Inc.
DNB vs ROOT
Xerox Holdings Corp
DNB vs XRX
GEO GROUP INC
DNB vs GEO
NATIONAL HEALTH INVESTORS INC
DNB vs NHI
AMERICAN TOWER CORP /MA/
DNB vs AMT
EQUINIX INC
DNB vs EQIX
Public Storage
DNB vs PSA
Extra Space Storage Inc.
DNB vs EXR
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe DNB can sustain its 42.0% EBITDA margin while improving growth from 2.9% and reducing net debt/EBITDA from 3.4x, then the DCF-based upside case is worth considering because CXW-implied range sits well below the DCF range.
The valuation gap is meaningful: DNB's CXW-implied price is $7.23-$11.99, while its DCF range is $16.36-$22.13, suggesting the market could be underestimating intrinsic value if those assumptions hold. However, the comparison is less clean because DNB lacks direct market multiples like P/S and EV/EBITDA in the provided data, limiting precision.
Supporting Metrics
